Compare CUE & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CUE | EVTL |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United Kingdom |
| Employees | 29 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.8M | 235.6M |
| IPO Year | 2017 | 2021 |
| Metric | CUE | EVTL |
|---|---|---|
| Price | $32.06 | $0.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $120.00 | $12.70 |
| AVG Volume (30 Days) | 170.5K | ★ 7.9M |
| Earning Date | 05-13-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,466,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 195.75 | N/A |
| 52 Week Low | $0.17 | $0.77 |
| 52 Week High | $45.50 | $7.35 |
| Indicator | CUE | EVTL |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 28.17 |
| Support Level | $24.68 | N/A |
| Resistance Level | $33.73 | $1.42 |
| Average True Range (ATR) | 3.25 | 0.11 |
| MACD | 0.12 | -0.03 |
| Stochastic Oscillator | 75.81 | 12.33 |
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.